The Sildenafil Drug Market Poised to Witness High Growth Owing to Increasing Prevalence of Erectile Dysfunction

Sildenafil Drug Market


 The sildenafil drug market comprises drugs used for the treatment of erectile dysfunction in men. Sildenafil, sold under the brand name Viagra among others, is a drug commonly used to treat erectile dysfunction and pulmonary arterial hypertension. It works by inhibiting phosphodiesterase type 5, increasing blood flow to the penis during sexual stimulation. The global sildenafil drug market is estimated to be valued at US$ 2.9 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Dynamics:

One of the key drivers propelling the growth of the sildenafil drug market is the increasing prevalence of erectile dysfunction among men. Erectile dysfunction is a common type of male sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Changing lifestyles, lack of physical activity, and growing consumption of tobacco and alcohol is contributing to the rising cases of erectile dysfunction, thereby fueling the demand for sildenafil drugs. Additionally, the popularity of generic versions of sildenafil drugs due to their low cost compared to branded drugs is also driving market growth. However, availability of alternative treatment options such as penile implants, counseling, lifestyle changes, and testosterone replacement therapy are factors expected to hamper the sildenafil drug market growth over the forecast period.

SWOT Analysis

Strength: Sildenafil drug is widely used for treating erectile dysfunction in men. It is known to be highly effective in resolving such issues within 30-60 minutes of consumption. Being an oral tablet, it offers easy administration to patients. Generic versions are also available at lower costs.

Weakness: Sildenafil may cause certain side effects like headaches, indigestion, blurred vision, back pain etc. in some users. There are also potential risks of hypotension, myocardial infarction on exertion, prolonged erection etc. It may not be suitable for patients suffering from certain conditions or those on some other medications.

Opportunity: The market has strong potential for growth in developing nations due to increasing awareness about lifestyle disorders and availability of generic drugs. Teleconsultation services are also promoting usage for such indications. Innovation in delivery forms like film, spray etc. may aid adherence and attract new consumers.

Threats: Entry of alternative drugs for treating erectile dysfunction and availability of herbal supplements in some markets pose competition. Regulations on direct-to-consumer marketing of such products can also limit promotions. Patent expiries of branded drugs enable availability of more affordable generics lowering potential revenues.


Key Takeaways

The global Sildenafil Drug Market Size is expected to witness high growth at a CAGR of 6.8% during the forecast period of 2023 to 2030. This can be attributed to rising prevalence of lifestyle disorders like diabetes impacting sexual health, growing health awareness regarding such issues and availability of generic alternatives at lower costs enhancing affordability.

Regional analysis: North America currently dominates with the highest market share owing to well established healthcare infrastructure and high adoption of advanced medications. However, Asia Pacific region is projected to emerge as the fastest growing market due to rising health expenditures, increasing patient pool of erectile dysfunction, growing health awareness and expanding penetration of generic drug manufacturers in nations like China and India.

Key players: Key players operating in the Sildenafil drug market are Pfizer, Teva Pharmaceuticals, Aurobindo Pharma, Alembic Pharmaceuticals, Torrent Pharmaceuticals, Lupin, Dr Reddy's Laboratories, Zydus Cadila, Amneal Pharmaceuticals, Hetero, Apotex, Mylan, Ajanta Pharma, Sun Pharmaceutical, Cipla, Novartis, Eli Lily, Sanofi, Bayer, GlaxoSmithKline. Along with product innovations and promotions, these companies are focused on expanding their presence across emerging markets to tap the future profitable opportunities.

For more insights, Read- https://www.ukwebwire.com/sildenafil-drug-market-growth-market-size-share-analysis/

Comments

Post a Comment

Popular posts from this blog

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the ...
Read more

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million ...
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv...
Read more